肌萎缩侧索硬化
生物
基因
突变体
细胞质
遗传学
突变
核糖核酸
基因突变
分子生物学
病理
医学
疾病
作者
Thomas J. Kwiatkowski,Daryl A. Bosco,A. L. LeClerc,Eric Tamrazian,Charles Vanderburg,C Russ,Adam Davis,James M. Gilchrist,Edward J. Kasarskis,T. L. Munsat,Paul N. Valdmanis,Guy A. Rouleau,Betsy A. Hosler,Pietro Cortelli,Pieter J. de Jong,Yuko Yoshinaga,J. L. Haines,Margaret A. Pericak‐Vance,J Yan,Nicola Ticozzi
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2009-02-26
卷期号:323 (5918): 1205-1208
被引量:2433
标识
DOI:10.1126/science.1166066
摘要
Amyotrophic lateral sclerosis (ALS) is a fatal degenerative motor neuron disorder. Ten percent of cases are inherited; most involve unidentified genes. We report here 13 mutations in the fused in sarcoma/translated in liposarcoma (FUS/TLS) gene on chromosome 16 that were specific for familial ALS. The FUS/TLS protein binds to RNA, functions in diverse processes, and is normally located predominantly in the nucleus. In contrast, the mutant forms of FUS/TLS accumulated in the cytoplasm of neurons, a pathology that is similar to that of the gene TAR DNA-binding protein 43 (TDP43), whose mutations also cause ALS. Neuronal cytoplasmic protein aggregation and defective RNA metabolism thus appear to be common pathogenic mechanisms involved in ALS and possibly in other neurodegenerative disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI